Search: id:"swepub:oai:DiVA.org:uu-22162" >
Determinants of car...
Determinants of cardiovascular risk in 2589 hypopituitary GH-deficient adults - a KIMS database analysis.
- Article/chapterEnglish2006
Publisher, publication year, extent ...
-
Oxford University Press (OUP),2006
-
printrdacarrier
Numbers
-
LIBRIS-ID:oai:DiVA.org:uu-22162
-
https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-22162URI
-
https://doi.org/10.1530/eje.1.02179DOI
Supplementary language notes
-
Language:English
-
Summary in:English
Part of subdatabase
Classification
-
Subject category:ref swepub-contenttype
-
Subject category:art swepub-publicationtype
Notes
-
Objective: The aim of the present study was to clarify the relationship between GH deficiency (GHD) andsome cardiovascular risk factors and to analyse the effect of GH replacement therapy in a large numberof patients over a prolonged period of time.Design: Data for analysis were retrieved from KIMS (Pfizer International Metabolic Database). Serumconcentrations of total cholesterol, high-density lipoprotein (HDL)-cholesterol, low-density lipoprotein(LDL)-cholesterol and triglycerides were obtained from 2589 patients at baseline and from 1206patients after 1 and 2 years of GH replacement therapy. Body mass index (BMI), waist and hip, restingblood pressure and body composition were also measured.Results: At baseline, the unfavourable effects of GHD were most obvious in the lipid profiledemonstrating elevated mean total and LDL-cholesterol, in the increased waist circumference and theelevated BMI. The cholesterol concentration, BMI and body composition were significantly adverselyaffected by a number of factors, including age, sex and the use of anti-epileptic drugs. The therapeuticeffect of GH was essentially uniform across the whole population. GH replacement reduced significantlythe mean total and LDL-cholesterol, the waist circumference and the fat mass and was maintainedduring 2 years.Conclusions: This analysis of a large number of patients confirmed that GHD adults present with anincreased cardiovascular risk. The sustained improvement of the adverse lipid profile and bodycomposition suggests that GH replacement therapy may reduce the risk of cardiovascular disease andthe premature mortality seen in hypopituitary patients with untreated GHD.
Subject headings and genre
-
Adult
-
Age Factors
-
Age of Onset
-
Aged
-
Blood Pressure/physiology
-
Body Composition/physiology
-
Body Mass Index
-
Cardiovascular Diseases/blood/*epidemiology/*etiology
-
Cholesterol/blood
-
Cholesterol; HDL/blood
-
Cholesterol; LDL/blood
-
Databases; Factual
-
Female
-
Growth Hormone/therapeutic use
-
Hormone Replacement Therapy
-
Human Growth Hormone/*deficiency
-
Humans
-
Hypopituitarism/*complications/drug therapy
-
Insulin-Like Growth Factor I/metabolism
-
Male
-
Middle Aged
-
Regression Analysis
-
Risk Factors
-
Sex Factors
-
Triglycerides/blood
-
Waist-Hip Ratio
-
MEDICINE
-
MEDICIN
Added entries (persons, corporate bodies, meetings, titles ...)
-
Feldt-Rasmussen, Ulla
(author)
-
Mattsson, Anders F
(author)
-
Monson, John P
(author)
-
Bengtsson, Bengt-Ake
(author)
-
Goth, M I
(author)
-
Wilton, Patrick
(author)
-
Koltowska-Häggström, MariaUppsala universitet,Institutionen för farmaci
(author)
-
Uppsala universitetInstitutionen för farmaci
(creator_code:org_t)
Related titles
-
In:European Journal of Endocrinology: Oxford University Press (OUP)155:1, s. 79-900804-46431479-683X
Internet link
Find in a library
To the university's database